Familial hypercholesterolaemia trials in Switzerland

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Geneva

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• No phaseTaking people
  A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

  Where

  Basel

  Age

  18 years to 99 years

  People

  5,995

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07543731